InspireMD Launches CGuard Prime Carotid Stent System in the U.S.

Stock Information for InspireMD Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About InspireMD Inc.

Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
InspireMD Reports Third Quarter 2025 Financial Results
InspireMD Names Peter A. Soukas, M.D., as Chief Medical Officer
InspireMD to Announce Third Quarter 2025 Financial Results
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.